BONUS！！！ CertJuken PMI-CPMAIダンプの一部を無料でダウンロード：https://drive.google.com/open?id=1AcBUkQFi8riiN6fBDvBaaJr_7spuiEBs
弊社CertJukenの資料を使用すると、最短でPMI Certified Professional in Managing AIの最高の質問トレントを習得し、他のことを完了するための時間とエネルギーを節約できます。 最も重要なのは、PMIのPMI Certified Professional in Managing AI学習資料を安全にPMI-CPMAIダウンロード、PMI-CPMAIインストール、使用できることです。 製品にウイルスがないことを保証できます。 それだけでなく、最高のサービスと最高のPMIのPMI Certified Professional in Managing AI試験トレントを提供し、製品の品質が良好であることを保証できます。 そのため、購入後はお気軽にご利用ください。お金を無駄にさせません。
| トピック | 出題範囲 |
|---|---|
| トピック 1 |
|
| トピック 2 |
|
| トピック 3 |
|
| トピック 4 |
|
| トピック 5 |
|
私たちPMIのPMI-CPMAI学習クイズは、仕上げの体系的な分析の分野での近年の試験状況のさまざまな専門家から作られ、学生の要求をできるだけ満たし、同時にチェックとレビューを行う専門スタッフがいますPMI-CPMAI実践教材、学生の学習に高品質の情報を楽しんでもらいました。 試験の多様性により、CertJukenのPMI-CPMAI学習教材もさまざまな種類の学習教材にまとめられているため、学生は必要なPMI-CPMAIガイド急流の情報をすばやく見つけることができます。
質問 # 125
During the initial phase of an AI project, the team is assessing project success criteria. The project manager discovers that the project may be violating some compliance rules.
What problem describes the issue the project team is facing?
正解：B
解説：
In the PMI-CPMAI view of AI project governance, one of the earliest and most critical responsibilities in the lifecycle is the identification of all applicable legal, regulatory, and policy requirements, especially those related to data usage, storage, transfer, and retention. When a project reaches the stage of defining success criteria and only then discovers that it may be violating compliance rules, this is characterized as a failure to identify data and AI-related regulations early in the project.
PMI-CPMAI stresses that regulatory scoping must be done in the initiation and planning phases, before detailed design and implementation, because regulations fundamentally constrain what data can be used, how it can be processed, and which AI techniques are permissible. Missing this step leads to rework, redesign, and in some cases project stoppage. It is not primarily a problem of unclear business objectives, nor of separating cognitive vs noncognitive components, nor simply a missing go/no-go gate. Instead, the core issue is that the team did not perform a sufficiently thorough regulatory and compliance assessment at the outset, so non-compliant practices surfaced only later. Hence, the problem is best described as failure to identify applicable data regulations early on.
質問 # 126
During the configuration management of an AI/machine learning (ML) model, the team has observed inconsistent performance metrics across different test datasets.
What will cause the inconsistency issue?
正解：C
解説：
PMI-CPMAI highlights data pipelines and preprocessing as critical components of AI/ML configuration management. A core principle is that all evaluation datasets must be processed through consistent, validated preprocessing steps (cleaning, normalization, feature engineering, encoding, etc.). If different test datasets experience different preprocessing logic, parameter settings, or transformations, performance metrics will naturally appear inconsistent, not because of the model itself but because the inputs are not comparable.
The guidance notes that configuration management for AI must track not only model versions but also data transformations, feature pipelines, and parameter settings. Inconsistent metrics across test datasets are a classic symptom of mismatched preprocessing, such as applying different scaling, missing-value handling, text tokenization, or feature selection strategies across datasets. Overfitting and model complexity affect generalization, but typically manifest as consistently poor performance on out-of-sample data, rather than erratic metrics between test sets prepared correctly.
Therefore, when a team observes inconsistent performance metrics across different test datasets, PMI-CPMAI would direct them to first check whether the data preprocessing steps are implemented correctly and consistently across those datasets. The likely cause of the inconsistency issue is incorrect (or inconsistent) data preprocessing steps.
質問 # 127
A project team is trying to determine the most suitable environment to operationalize their AI/machine learning (ML) solution. They need to consider various factors to help ensure a successful implementation.
What should the project manager do?
正解：C
解説：
When choosing an environment to operationalize an AI/ML solution, PMI-CPMAI guidance stresses starting from stakeholders and end-user interactions, then deriving technical choices (infrastructure, deployment model, integration pattern) from those needs. Identifying who the end users are, how they will interact with the system, and in which workflows and channels is crucial. This includes understanding whether the AI will be consumed via dashboards, embedded in existing applications, via APIs, or as decision support in specific business processes.
Once these interaction patterns are clear, the project manager and technical team can determine environment needs: latency requirements, availability, integration points, security boundaries, on-prem vs. cloud, edge vs.
centralized deployment, and needed tooling for monitoring and MLOps. Scalability (option A), cost (option B), and compliance (option D) are all important factors, but they are secondary considerations that should be evaluated in the context of how users will actually use the system.
PMI's AI lifecycle view emphasizes that environment and architecture decisions must be requirements- driven, not purely cost- or technology-driven. Therefore, the project manager should first identify the end users and their interactions with the solution (option C) as the basis for selecting the most suitable operational environment.
質問 # 128
A healthcare provider is operationalizing an AI tool to assist in diagnostic processes. To ensure robust model governance, they need to address data privacy and ethical considerations.
What should the project manager do?
正解：C
解説：
Within PMI-CPMAI-aligned responsible AI practices, deploying AI in healthcare diagnostics requires explicit attention to data privacy, regulatory compliance, and ethical impact on patients. A Privacy Impact Assessment (PIA) is a structured method used to systematically identify, analyze, and mitigate privacy and ethical risks associated with data processing and automated decisions. For an operationalized diagnostic AI tool, a PIA helps the project manager map data flows (collection, storage, use, and sharing), determine the legal basis for processing sensitive health data, highlight potential harms (misuse, breaches, inappropriate access), and define safeguards such as minimization, anonymization, consent handling, and access controls.
PMI-CP-consistent AI governance emphasizes documenting how data is used and how decisions affect individuals, as well as demonstrating that privacy and ethical considerations have been proactively assessed before and during operation. While internal frameworks or protocols (such as generic monitoring or controls) may help manage performance and operations, they do not replace a formal, focused assessment of privacy risk and ethical implications. A PIA provides concrete evidence that the organization has anticipated the effect of the AI system on patient rights, confidentiality, and trust, making it the most suitable action in this context.
Therefore, the project manager should develop a detailed privacy impact assessment (PIA).
質問 # 129
A healthcare organization is preparing training data for an AI model that predicts patient readmissions. The team discovers inconsistent coding across clinics for the same diagnosis. Which action best addresses the problem during data preparation?
正解：D
解説：
PMI-CPMAI aligns data preparation with executing data cleansing and enhancement activities so that datasets meet model and operational requirements. Inconsistent clinical coding is a data quality issue that threatens accuracy, fairness, and interpretability, because identical conditions may be represented differently across sources. The PMI-aligned response is to determine and apply the necessary transformation steps- standardizing codes to a controlled vocabulary, mapping local codes to a canonical schema, normalizing formats, and documenting rules and lineage so the process is auditable. Ignoring inconsistencies (B) increases noise and can embed systematic bias (e.g., certain clinics appearing "higher risk" due to coding artifacts).
Relying only on synthetic data (C) can reduce fidelity if the synthetic process fails to reflect true clinical distributions. Skipping validation (D) violates responsible delivery expectations because it undermines patient safety and data integrity. PMI's responsible and trustworthy framing supports disciplined data readiness work before model development proceeds.
質問 # 130
......
IT職員の一員として、目前のPMIのPMI-CPMAI試験情報を明らかに了解できますか？もし了解しなかったら、心配する必要がありません。我々社CertJukenは試験政策の変化に応じて、PMIのPMI-CPMAI問題集をタイムリーに更新しています。こうした、お客様に完備かつ高品質のPMI-CPMAI試験資料を提供できます。
PMI-CPMAI日本語版復習資料: https://www.certjuken.com/PMI-CPMAI-exam.html
ちなみに、CertJuken PMI-CPMAIの一部をクラウドストレージからダウンロードできます：https://drive.google.com/open?id=1AcBUkQFi8riiN6fBDvBaaJr_7spuiEBs